nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—Blood glucose decreased—Vandetanib—thyroid cancer	0.105	0.134	CcSEcCtD
Bromazepam—White blood cell count decreased—Vandetanib—thyroid cancer	0.0479	0.0613	CcSEcCtD
Bromazepam—Haemoglobin decreased—Vandetanib—thyroid cancer	0.0347	0.0443	CcSEcCtD
Bromazepam—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0234	0.0299	CcSEcCtD
Bromazepam—Depressed level of consciousness—Vandetanib—thyroid cancer	0.023	0.0295	CcSEcCtD
Bromazepam—Cardiac failure—Vandetanib—thyroid cancer	0.0177	0.0227	CcSEcCtD
Bromazepam—GABRA3—neck—thyroid cancer	0.0166	0.0762	CbGeAlD
Bromazepam—Cardiac arrest—Vandetanib—thyroid cancer	0.0165	0.0211	CcSEcCtD
Bromazepam—Cardiac failure—Sorafenib—thyroid cancer	0.012	0.0153	CcSEcCtD
Bromazepam—GABRR3—head—thyroid cancer	0.0112	0.0514	CbGeAlD
Bromazepam—GABRQ—head—thyroid cancer	0.0112	0.0514	CbGeAlD
Bromazepam—Eye disorder—Vandetanib—thyroid cancer	0.0112	0.0143	CcSEcCtD
Bromazepam—Cardiac disorder—Vandetanib—thyroid cancer	0.0111	0.0142	CcSEcCtD
Bromazepam—Mental disorder—Vandetanib—thyroid cancer	0.0105	0.0134	CcSEcCtD
Bromazepam—Malnutrition—Vandetanib—thyroid cancer	0.0104	0.0133	CcSEcCtD
Bromazepam—Muscle spasms—Vandetanib—thyroid cancer	0.01	0.0128	CcSEcCtD
Bromazepam—Vision blurred—Vandetanib—thyroid cancer	0.00983	0.0126	CcSEcCtD
Bromazepam—GABRG3—head—thyroid cancer	0.00982	0.045	CbGeAlD
Bromazepam—Tremor—Vandetanib—thyroid cancer	0.00977	0.0125	CcSEcCtD
Bromazepam—GABRR2—head—thyroid cancer	0.00972	0.0445	CbGeAlD
Bromazepam—GABRP—trachea—thyroid cancer	0.00968	0.0444	CbGeAlD
Bromazepam—GABRR1—head—thyroid cancer	0.00935	0.0429	CbGeAlD
Bromazepam—Convulsion—Vandetanib—thyroid cancer	0.00904	0.0116	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00882	0.0113	CcSEcCtD
Bromazepam—Dry mouth—Vandetanib—thyroid cancer	0.00868	0.0111	CcSEcCtD
Bromazepam—Nervous system disorder—Vandetanib—thyroid cancer	0.00835	0.0107	CcSEcCtD
Bromazepam—Skin disorder—Vandetanib—thyroid cancer	0.00827	0.0106	CcSEcCtD
Bromazepam—GABRD—head—thyroid cancer	0.00813	0.0373	CbGeAlD
Bromazepam—Connective tissue disorder—Sorafenib—thyroid cancer	0.00794	0.0102	CcSEcCtD
Bromazepam—GABRA3—thyroid gland—thyroid cancer	0.00792	0.0363	CbGeAlD
Bromazepam—GABRG1—head—thyroid cancer	0.00782	0.0359	CbGeAlD
Bromazepam—GABRA6—head—thyroid cancer	0.00778	0.0357	CbGeAlD
Bromazepam—GABRB1—head—thyroid cancer	0.00759	0.0348	CbGeAlD
Bromazepam—GABRA5—head—thyroid cancer	0.00755	0.0346	CbGeAlD
Bromazepam—Cardiac disorder—Sorafenib—thyroid cancer	0.0075	0.00959	CcSEcCtD
Bromazepam—Dyspepsia—Vandetanib—thyroid cancer	0.00749	0.00958	CcSEcCtD
Bromazepam—Decreased appetite—Vandetanib—thyroid cancer	0.0074	0.00946	CcSEcCtD
Bromazepam—GABRE—trachea—thyroid cancer	0.00739	0.0339	CbGeAlD
Bromazepam—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00735	0.0094	CcSEcCtD
Bromazepam—Fatigue—Vandetanib—thyroid cancer	0.00734	0.00939	CcSEcCtD
Bromazepam—Mental disorder—Sorafenib—thyroid cancer	0.00708	0.00906	CcSEcCtD
Bromazepam—Malnutrition—Sorafenib—thyroid cancer	0.00703	0.009	CcSEcCtD
Bromazepam—GABRA3—head—thyroid cancer	0.00703	0.0322	CbGeAlD
Bromazepam—GABRA4—head—thyroid cancer	0.00685	0.0314	CbGeAlD
Bromazepam—GABRR2—lymph node—thyroid cancer	0.0068	0.0312	CbGeAlD
Bromazepam—GABRP—head—thyroid cancer	0.0068	0.0311	CbGeAlD
Bromazepam—Muscle spasms—Sorafenib—thyroid cancer	0.00676	0.00865	CcSEcCtD
Bromazepam—Asthenia—Vandetanib—thyroid cancer	0.00611	0.00781	CcSEcCtD
Bromazepam—Pruritus—Vandetanib—thyroid cancer	0.00602	0.0077	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00595	0.00761	CcSEcCtD
Bromazepam—Dry mouth—Sorafenib—thyroid cancer	0.00586	0.00749	CcSEcCtD
Bromazepam—GABRE—thyroid gland—thyroid cancer	0.00585	0.0268	CbGeAlD
Bromazepam—Anaphylactic shock—Sorafenib—thyroid cancer	0.00574	0.00734	CcSEcCtD
Bromazepam—GABRG2—head—thyroid cancer	0.00573	0.0262	CbGeAlD
Bromazepam—GABRB2—head—thyroid cancer	0.00573	0.0262	CbGeAlD
Bromazepam—Nervous system disorder—Sorafenib—thyroid cancer	0.00563	0.0072	CcSEcCtD
Bromazepam—Dizziness—Vandetanib—thyroid cancer	0.00563	0.0072	CcSEcCtD
Bromazepam—Skin disorder—Sorafenib—thyroid cancer	0.00558	0.00713	CcSEcCtD
Bromazepam—Anorexia—Sorafenib—thyroid cancer	0.00547	0.007	CcSEcCtD
Bromazepam—Vomiting—Vandetanib—thyroid cancer	0.00541	0.00692	CcSEcCtD
Bromazepam—Rash—Vandetanib—thyroid cancer	0.00537	0.00686	CcSEcCtD
Bromazepam—Dermatitis—Vandetanib—thyroid cancer	0.00536	0.00686	CcSEcCtD
Bromazepam—Headache—Vandetanib—thyroid cancer	0.00533	0.00682	CcSEcCtD
Bromazepam—GABRA2—head—thyroid cancer	0.00523	0.024	CbGeAlD
Bromazepam—GABRE—head—thyroid cancer	0.00519	0.0238	CbGeAlD
Bromazepam—GABRA1—head—thyroid cancer	0.00506	0.0232	CbGeAlD
Bromazepam—Nausea—Vandetanib—thyroid cancer	0.00506	0.00647	CcSEcCtD
Bromazepam—Dyspepsia—Sorafenib—thyroid cancer	0.00505	0.00646	CcSEcCtD
Bromazepam—Decreased appetite—Sorafenib—thyroid cancer	0.00499	0.00638	CcSEcCtD
Bromazepam—GABRB3—thyroid gland—thyroid cancer	0.00496	0.0227	CbGeAlD
Bromazepam—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00496	0.00634	CcSEcCtD
Bromazepam—Fatigue—Sorafenib—thyroid cancer	0.00495	0.00633	CcSEcCtD
Bromazepam—Cardiac failure—Epirubicin—thyroid cancer	0.00442	0.00566	CcSEcCtD
Bromazepam—GABRB3—head—thyroid cancer	0.0044	0.0202	CbGeAlD
Bromazepam—Diplopia—Epirubicin—thyroid cancer	0.00432	0.00552	CcSEcCtD
Bromazepam—Hypersensitivity—Sorafenib—thyroid cancer	0.00423	0.00541	CcSEcCtD
Bromazepam—Asthenia—Sorafenib—thyroid cancer	0.00412	0.00527	CcSEcCtD
Bromazepam—Cardiac arrest—Epirubicin—thyroid cancer	0.0041	0.00525	CcSEcCtD
Bromazepam—Cardiac failure—Doxorubicin—thyroid cancer	0.00409	0.00524	CcSEcCtD
Bromazepam—Pruritus—Sorafenib—thyroid cancer	0.00406	0.0052	CcSEcCtD
Bromazepam—Ataxia—Epirubicin—thyroid cancer	0.00406	0.00519	CcSEcCtD
Bromazepam—Diplopia—Doxorubicin—thyroid cancer	0.00399	0.00511	CcSEcCtD
Bromazepam—Muscular weakness—Epirubicin—thyroid cancer	0.00381	0.00487	CcSEcCtD
Bromazepam—Cardiac arrest—Doxorubicin—thyroid cancer	0.0038	0.00486	CcSEcCtD
Bromazepam—Dizziness—Sorafenib—thyroid cancer	0.0038	0.00486	CcSEcCtD
Bromazepam—Ataxia—Doxorubicin—thyroid cancer	0.00376	0.0048	CcSEcCtD
Bromazepam—GABRA2—lymph node—thyroid cancer	0.00366	0.0168	CbGeAlD
Bromazepam—Vomiting—Sorafenib—thyroid cancer	0.00365	0.00467	CcSEcCtD
Bromazepam—GABRE—lymph node—thyroid cancer	0.00363	0.0166	CbGeAlD
Bromazepam—Rash—Sorafenib—thyroid cancer	0.00362	0.00463	CcSEcCtD
Bromazepam—Dermatitis—Sorafenib—thyroid cancer	0.00362	0.00463	CcSEcCtD
Bromazepam—Headache—Sorafenib—thyroid cancer	0.0036	0.0046	CcSEcCtD
Bromazepam—Muscular weakness—Doxorubicin—thyroid cancer	0.00352	0.00451	CcSEcCtD
Bromazepam—CYP1A2—thyroid gland—thyroid cancer	0.00351	0.0161	CbGeAlD
Bromazepam—Nausea—Sorafenib—thyroid cancer	0.00341	0.00436	CcSEcCtD
Bromazepam—Drowsiness—Epirubicin—thyroid cancer	0.00333	0.00426	CcSEcCtD
Bromazepam—CYP2E1—thyroid gland—thyroid cancer	0.00315	0.0145	CbGeAlD
Bromazepam—Drowsiness—Doxorubicin—thyroid cancer	0.00308	0.00394	CcSEcCtD
Bromazepam—Connective tissue disorder—Epirubicin—thyroid cancer	0.00293	0.00375	CcSEcCtD
Bromazepam—CYP2E1—head—thyroid cancer	0.0028	0.0128	CbGeAlD
Bromazepam—Eye disorder—Epirubicin—thyroid cancer	0.00279	0.00357	CcSEcCtD
Bromazepam—Cardiac disorder—Epirubicin—thyroid cancer	0.00277	0.00355	CcSEcCtD
Bromazepam—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00272	0.00347	CcSEcCtD
Bromazepam—Mental disorder—Epirubicin—thyroid cancer	0.00262	0.00335	CcSEcCtD
Bromazepam—Malnutrition—Epirubicin—thyroid cancer	0.0026	0.00333	CcSEcCtD
Bromazepam—Eye disorder—Doxorubicin—thyroid cancer	0.00258	0.0033	CcSEcCtD
Bromazepam—Cardiac disorder—Doxorubicin—thyroid cancer	0.00256	0.00328	CcSEcCtD
Bromazepam—Tension—Epirubicin—thyroid cancer	0.00255	0.00326	CcSEcCtD
Bromazepam—Nervousness—Epirubicin—thyroid cancer	0.00253	0.00323	CcSEcCtD
Bromazepam—Muscle spasms—Epirubicin—thyroid cancer	0.0025	0.0032	CcSEcCtD
Bromazepam—Vision blurred—Epirubicin—thyroid cancer	0.00245	0.00313	CcSEcCtD
Bromazepam—Mental disorder—Doxorubicin—thyroid cancer	0.00242	0.0031	CcSEcCtD
Bromazepam—Malnutrition—Doxorubicin—thyroid cancer	0.00241	0.00308	CcSEcCtD
Bromazepam—Agitation—Epirubicin—thyroid cancer	0.00239	0.00306	CcSEcCtD
Bromazepam—Tension—Doxorubicin—thyroid cancer	0.00236	0.00302	CcSEcCtD
Bromazepam—Nervousness—Doxorubicin—thyroid cancer	0.00234	0.00299	CcSEcCtD
Bromazepam—Muscle spasms—Doxorubicin—thyroid cancer	0.00231	0.00296	CcSEcCtD
Bromazepam—Palpitations—Epirubicin—thyroid cancer	0.0023	0.00294	CcSEcCtD
Bromazepam—Vision blurred—Doxorubicin—thyroid cancer	0.00227	0.0029	CcSEcCtD
Bromazepam—Convulsion—Epirubicin—thyroid cancer	0.00225	0.00288	CcSEcCtD
Bromazepam—Agitation—Doxorubicin—thyroid cancer	0.00221	0.00283	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.0022	0.00281	CcSEcCtD
Bromazepam—Dry mouth—Epirubicin—thyroid cancer	0.00216	0.00277	CcSEcCtD
Bromazepam—Confusional state—Epirubicin—thyroid cancer	0.00214	0.00274	CcSEcCtD
Bromazepam—Palpitations—Doxorubicin—thyroid cancer	0.00213	0.00272	CcSEcCtD
Bromazepam—Anaphylactic shock—Epirubicin—thyroid cancer	0.00212	0.00271	CcSEcCtD
Bromazepam—Convulsion—Doxorubicin—thyroid cancer	0.00208	0.00267	CcSEcCtD
Bromazepam—Nervous system disorder—Epirubicin—thyroid cancer	0.00208	0.00266	CcSEcCtD
Bromazepam—Tachycardia—Epirubicin—thyroid cancer	0.00207	0.00265	CcSEcCtD
Bromazepam—Skin disorder—Epirubicin—thyroid cancer	0.00206	0.00264	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00203	0.0026	CcSEcCtD
Bromazepam—Anorexia—Epirubicin—thyroid cancer	0.00202	0.00259	CcSEcCtD
Bromazepam—Dry mouth—Doxorubicin—thyroid cancer	0.002	0.00256	CcSEcCtD
Bromazepam—Hypotension—Epirubicin—thyroid cancer	0.00198	0.00254	CcSEcCtD
Bromazepam—Confusional state—Doxorubicin—thyroid cancer	0.00198	0.00253	CcSEcCtD
Bromazepam—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00196	0.00251	CcSEcCtD
Bromazepam—Nervous system disorder—Doxorubicin—thyroid cancer	0.00193	0.00246	CcSEcCtD
Bromazepam—Tachycardia—Doxorubicin—thyroid cancer	0.00192	0.00245	CcSEcCtD
Bromazepam—Skin disorder—Doxorubicin—thyroid cancer	0.00191	0.00244	CcSEcCtD
Bromazepam—Somnolence—Epirubicin—thyroid cancer	0.00189	0.00241	CcSEcCtD
Bromazepam—Anorexia—Doxorubicin—thyroid cancer	0.00187	0.00239	CcSEcCtD
Bromazepam—Dyspepsia—Epirubicin—thyroid cancer	0.00187	0.00239	CcSEcCtD
Bromazepam—Decreased appetite—Epirubicin—thyroid cancer	0.00184	0.00236	CcSEcCtD
Bromazepam—Hypotension—Doxorubicin—thyroid cancer	0.00183	0.00235	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00183	0.00234	CcSEcCtD
Bromazepam—Fatigue—Epirubicin—thyroid cancer	0.00183	0.00234	CcSEcCtD
Bromazepam—Feeling abnormal—Epirubicin—thyroid cancer	0.00175	0.00224	CcSEcCtD
Bromazepam—Somnolence—Doxorubicin—thyroid cancer	0.00175	0.00223	CcSEcCtD
Bromazepam—Dyspepsia—Doxorubicin—thyroid cancer	0.00173	0.00221	CcSEcCtD
Bromazepam—Decreased appetite—Doxorubicin—thyroid cancer	0.00171	0.00218	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00169	0.00217	CcSEcCtD
Bromazepam—Fatigue—Doxorubicin—thyroid cancer	0.00169	0.00217	CcSEcCtD
Bromazepam—Feeling abnormal—Doxorubicin—thyroid cancer	0.00162	0.00207	CcSEcCtD
Bromazepam—Hypersensitivity—Epirubicin—thyroid cancer	0.00156	0.002	CcSEcCtD
Bromazepam—Asthenia—Epirubicin—thyroid cancer	0.00152	0.00195	CcSEcCtD
Bromazepam—Pruritus—Epirubicin—thyroid cancer	0.0015	0.00192	CcSEcCtD
Bromazepam—Hypersensitivity—Doxorubicin—thyroid cancer	0.00145	0.00185	CcSEcCtD
Bromazepam—Asthenia—Doxorubicin—thyroid cancer	0.00141	0.0018	CcSEcCtD
Bromazepam—Dizziness—Epirubicin—thyroid cancer	0.0014	0.00179	CcSEcCtD
Bromazepam—Pruritus—Doxorubicin—thyroid cancer	0.00139	0.00178	CcSEcCtD
Bromazepam—Vomiting—Epirubicin—thyroid cancer	0.00135	0.00173	CcSEcCtD
Bromazepam—Rash—Epirubicin—thyroid cancer	0.00134	0.00171	CcSEcCtD
Bromazepam—Dermatitis—Epirubicin—thyroid cancer	0.00134	0.00171	CcSEcCtD
Bromazepam—Headache—Epirubicin—thyroid cancer	0.00133	0.0017	CcSEcCtD
Bromazepam—Dizziness—Doxorubicin—thyroid cancer	0.0013	0.00166	CcSEcCtD
Bromazepam—Nausea—Epirubicin—thyroid cancer	0.00126	0.00161	CcSEcCtD
Bromazepam—Vomiting—Doxorubicin—thyroid cancer	0.00125	0.0016	CcSEcCtD
Bromazepam—Rash—Doxorubicin—thyroid cancer	0.00124	0.00158	CcSEcCtD
Bromazepam—Dermatitis—Doxorubicin—thyroid cancer	0.00124	0.00158	CcSEcCtD
Bromazepam—Headache—Doxorubicin—thyroid cancer	0.00123	0.00157	CcSEcCtD
Bromazepam—Nausea—Doxorubicin—thyroid cancer	0.00117	0.00149	CcSEcCtD
